![](/img/cover-not-exists.png)
Capacity of the manufacturing process of Flebogamma® DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agent
José M. Diez, Santiago Caballero, Francisco Belda, Magdalena Otegui, Rodrigo Gajardo, Juan I. JorqueraVolume:
38
Year:
2010
Language:
english
Pages:
5
DOI:
10.1016/j.biologicals.2010.08.003
File:
PDF, 232 KB
english, 2010